I am sorry, but you have it exactly backwards.
First, getting a glucose in a patient who has no clinical signs of hyper- or hypo- glycemia does not give you a better picture of what’s going on. 9/10 times, it will simply tell you what you already know: that their BG is normal. Maybe 0.5 or 1 out of 10 times, the BG will be out of the range you expected. But if they are asymptomatic, so what? Are you going to give glucose to someone whose BG is 55, if they look and feel just fine? Are you going to give insulin to someone whose BG is 300, if they look and feel normal? Of course not. So why are you even looking?
Second, there is a strong movement in healthcare right now away from doing tests "just because" and towards only doing testing that is clinically indicated and that will directly affect your care of the patient. This is happening for several reasons:
- Unnecessary testing is just that....unnecessary. If you don't need a piece of data to make the decision you are trying to make, then you just don't need that piece of data.
- Cost. Even very cheap tests add up very fast when you do them on lots of patients.
- Risk to the patient. Patients are actually killed every year by unnecessary treatments that they received as a result of inaccurate or anomalous results that came from tests that weren’t even indicated for their condition. Most of those tests were done "just because" they were "cheap and harmless".
- Legal risk to you or your company. Charting abnormalities (say, a BG of 400) and then not treating it is inviting questions about your care from a non-clinician who may be reviewing the chart for some reason. It's just another reason not to bother looking for something that you aren't going to treat.
The problem isn’t so much with the practice of routinely checking a BG with IV starts. The problem is with the general mindset that “more info is always better” and “cost doesn’t matter as long as it’s low”, and ignoring the fact that patients are, in fact, exposed to some level of additional risk with testing.
This hits the nail right on the head: